217 episodes

Podcast by STAT

The Readout Loud STAT

    • Business
    • 4.6 • 248 Ratings

Podcast by STAT

    215: Medical privacy post-Roe, fixing clinical trials, & the next Covid vaccines

    215: Medical privacy post-Roe, fixing clinical trials, & the next Covid vaccines

    How do you stop a Covid surge? Why are clinical trials so white? And what are the limits of HIPAA? Our colleague Eric Boodman joins us to discuss whether an oft-cited federal law can shield reproductive health data from state law enforcement in the wake of Roe v. Wade being overturned. Then, STAT's Angus Chen calls in to relate the story of an ambitious study and the quest to finally make clinical trials more equitable. We also explain a momentous FDA meeting and the debate over just what the Covid-19 vaccines of the future should contain.

    • 34 min
    214: Juul's doomsday, Merck's buyout plans, & the next Theranos verdict

    214: Juul's doomsday, Merck's buyout plans, & the next Theranos verdict

    Just how powerful is the FDA? Is Merck about to spend $40 billion? And what's a "Puff Bar"? STAT Washington correspondent Nicholas Florko joins us to discuss the FDA's decision to ban the sale of Juul Labs vaping products and a proposal to reduce the amount of nicotine in cigarettes. We’ll also explain the latest news in the life sciences, including a rumored blockbuster buyout and the next Theranos verdict.

    • 27 min
    213: How the Fed affects biotech, Paul Offit on vaccines for kids, & another Alzheimer's setback

    213: How the Fed affects biotech, Paul Offit on vaccines for kids, & another Alzheimer's setback

    Will biotech stocks ever recover? How well do Covid-19 vaccines work for kids? And can anything stop the amyloid hypothesis? Longtime biotech investor Les Funtleyder joins us to explain why the recent interest rate hike is bad for biotech and just what it will take for the industry to get out of its slump. Then, vaccinologist and FDA adviser Paul Offit calls in to talk about the impending authorization of Covid-19 vaccines for young children and what it means for the future of the pandemic. We also explain the latest disappointing clinical trial in Alzheimer's disease and some perplexing data on Pfizer's Covid-19 antiviral.

    • 35 min
    212: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy

    212: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy

    When is data "practice-changing"? How many Covid-19 vaccines do we need? And what does it mean when the FDA asks for more time? With the world's largest cancer conference just concluded, we explain the most important data presented at the meeting, including a blockbuster clinical trial that promises to change the treatment of advanced breast cancer. We also discuss an FDA controversy in the making, a pair of new Covid-19 vaccines, and the frustrating process of finding new treatments for depression.

    • 35 min
    211: Biotech's catch-22, a $100 genome, & dealing with monkeypox

    211: Biotech's catch-22, a $100 genome, & dealing with monkeypox

    Will gene therapy ever live up to expectations? Can anyone break up the genomics monopoly? And is innovation actually bad for biotech? This week, health care strategist Jared Holz of Oppenheimer joins us to discuss the weekend's big oncology conference and what it will take to change Wall Street's dire view of the drug industry. We also discuss a weighty FDA meeting on gene therapy, the potential of a $100 genome, and how the expanding monkeypox outbreak is creating challenges for public health agencies.

    • 33 min
    210: Covid vaccines for the youngest kids, ASCO preview, & a biotech CEO’s arrest on murder charges

    210: Covid vaccines for the youngest kids, ASCO preview, & a biotech CEO’s arrest on murder charges

    ovid vaccines for the youngest kids are up for review, but which jab — Moderna or Pfizer — will parents choose? What’s on tap for ASCO, the biggest cancer research conference of the year? And a biotech CEO has been arrested in an alleged murder-for-hire scheme. First, we chat about the latest news in the life sciences. Then, we’re joined by physician and parent Jeremy Faust to discuss his take on the Covid vaccine data for children under 5.

    • 34 min

Customer Reviews

4.6 out of 5
248 Ratings

248 Ratings

ocean 1435🐾 ,

Love this

Hi i love the podcast❤️❤️❤️❤️❤️❤️

reportinghygeine ,

Wrong Tone On the Murder for Hire

It sounds like someone was killed. If it was one of your close relatives you would be furious about the tone. Murder is serious, not funny, although I do understand that it’s not usually your beat. You come off as young, naive and lacking in character and wisdom.

CxxxxLxxxxx ,

Great for people who follow the biotech industry

Does a great job of reporting on and discussing the important developments in the biotech industry.

Top Podcasts In Business

Ramsey Network
Pushkin Industries
Jenna Kutcher
Jocko DEFCOR Network
iHeartPodcasts
Andy Frisella #100to0

You Might Also Like

Timmerman Report
BioCentury
NPR
The Wall Street Journal & Gimlet
Springer Nature Limited
Tradeoffs